Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act

J Antimicrob Chemother. 2008 Mar;61(3):469-73. doi: 10.1093/jac/dkm499. Epub 2008 Jan 3.

Abstract

Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era.

Publication types

  • Review

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / adverse effects
  • Antiretroviral Therapy, Highly Active / methods*
  • Gastrointestinal Diseases / chemically induced
  • Gastrointestinal Diseases / physiopathology
  • HIV Infections / drug therapy*
  • HIV Infections / physiopathology
  • Humans
  • Life Support Care / methods*
  • Life Support Care / trends
  • Quality of Life*